| Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early … HM Earl, AL Vallier, L Hiller, N Fenwick, J Young, M Iddawela, J Abraham, ... The lancet oncology 15 (2), 201-212, 2014 | 148 | 2014 |
| Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer HR Ali, A Dariush, E Provenzano, H Bardwell, JE Abraham, M Iddawela, ... Breast Cancer Research 18, 1-11, 2016 | 79 | 2016 |
| Ipilimumab-induced thrombocytopenia in a patient with metastatic melanoma S Ahmad, M Lewis, P Corrie, M Iddawela Journal of Oncology Pharmacy Practice 18 (2), 287-292, 2012 | 61 | 2012 |
| Understanding aboriginal peoples’ cultural and family connections can help inform the development of culturally appropriate cancer survivorship models of care E Ristevski, S Thompson, S Kingaby, C Nightingale, M Iddawela JCO Global Oncology 6, 124-132, 2020 | 40 | 2020 |
| A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial E Provenzano, AL Vallier, R Champ, K Walland, S Bowden, A Grier, ... British journal of cancer 108 (4), 866-872, 2013 | 40 | 2013 |
| Neo-tAnGo: A neoadjuvant randomized phase III trial of epirubicin/cyclophosphamide and paclitaxel±gemcitabine in the treatment of women with high-risk early breast cancer (EBC … HM Earl, A Vallier, L Hiller, N Fenwick, M Iddawela, L Hughes-Davies, ... Journal of Clinical Oncology 27 (15_suppl), 522-522, 2009 | 36 | 2009 |
| Accuracy of unidimensional and volumetric ultrasound measurements in predicting good pathological response to neoadjuvant chemotherapy in breast cancer patients I Gounaris, E Provenzano, AL Vallier, L Hiller, M Iddawela, S Hilborne, ... Breast cancer research and treatment 127, 459-469, 2011 | 29 | 2011 |
| Considerations for the processing and analysis of GoldenGate-based two-colour Illumina platforms AG Lynch, MJ Dunning, M Iddawela, NL Barbosa-Morais, ME Ritchie Statistical methods in medical research 18 (5), 437-452, 2009 | 25 | 2009 |
| Bevacizumab in advanced cervical cancer: issues and challenges for low-and middle-income countries B Gyawali, M Iddawela Journal of global oncology 3 (2), 93-97, 2017 | 24 | 2017 |
| Cheaper options in the prevention of chemotherapy-induced nausea and vomiting B Gyawali, BS Poudyal, M Iddawela Journal of Global Oncology 2 (3), 145-153, 2016 | 20 | 2016 |
| Safety and efficacy of vemurafenib in end stage renal failure M Iddawela, S Crook, L George, A Lakkaraju, N Nanayakkara, R Hunt, ... BMC cancer 13, 1-4, 2013 | 16 | 2013 |
| Epirubicin as adjuvant therapy in breast cancer H Earl, M Iddawela Expert Review of Anticancer Therapy 4 (2), 189-195, 2004 | 16 | 2004 |
| Epirubicin, cisplatin, and capecitabine for primary platinum-resistant or platinum-refractory epithelial ovarian cancer: results of a retrospective, single-institution study K Sayal, I Gounaris, B Basu, S Freeman, P Moyle, K Hosking, M Iddawela, ... International Journal of Gynecologic Cancer 25 (6), 2015 | 15 | 2015 |
| Integrative analysis of copy number and gene expression in breast cancer using formalin-fixed paraffin-embedded core biopsy tissue: a feasibility study M Iddawela, O Rueda, J Eremin, O Eremin, J Cowley, HM Earl, C Caldas BMC genomics 18, 1-13, 2017 | 14 | 2017 |
| Defining research and infrastructure priorities for cancer survivorship in Australia: a modified Delphi study F Crawford-Williams, B Koczwara, RJ Chan, J Vardy, K Lisy, J Morris, ... Supportive Care in Cancer 30 (5), 3805-3815, 2022 | 13 | 2022 |
| Reliable gene expression profiling of formalin-fixed paraffin-embedded breast cancer tissue (FFPE) using cDNA-mediated annealing, extension, selection, and ligation whole … M Iddawela, OM Rueda, M Klarqvist, S Graf, HM Earl, C Caldas BMC medical genomics 9, 1-9, 2016 | 13 | 2016 |
| Circulating oestrogen receptor mutations and splice variants in advanced prostate cancer LG Qu, H Wardan, ID Davis, M Iddawela, P Sluka, CJ Pezaro BJU international 124, 50-56, 2019 | 11 | 2019 |
| Continuous versus intermittent docetaxel for metastatic castration resistant prostate cancer B Gyawali, S Koomulli-Parambil, M Iddawela Critical Reviews in Oncology/Hematology 102, 118-124, 2016 | 11 | 2016 |
| The impact of bevacizumab in metastatic colorectal cancer with an intact primary tumor: Results from a large prospective cohort study B Lee, HL Wong, M Tacey, J Tie, R Wong, M Lee, L Nott, J Shapiro, ... Asia‐Pacific Journal of Clinical Oncology 13 (4), 314-321, 2017 | 10 | 2017 |
| Novel quality indicators for metastatic colorectal cancer management identify significant variations in these measures across treatment centers in A ustralia NH Turner, H Wong, K Field, R Wong, J Shapiro, D Yip, L Nott, J Tie, ... Asia‐Pacific Journal of Clinical Oncology 11 (3), 262-271, 2015 | 10 | 2015 |
